Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation.
Cellebrite DI stock last closed at $20.10, up 1.62% from the previous day, and has increased 85.25% in one year. It has overperformed other stocks in the Software - Infrastructure industry by 1.46 percentage points. Cellebrite DI stock is currently +96.19% from its 52-week low of $10.25, and -23.57% from its 52-week high of $26.30.
At the moment, there are 239.47M CLBT shares outstanding. The market capitalization of CLBT is $4.81B. In the last 24 hours, 469,665 CLBT shares were traded.
You need a brokerage account to access the NASDAQ market and buy CLBT stock.
Based on our research, eToro is the best stock brokerage. eToro gives you:
Get $10 towards your purchase of stock by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've picked the best brokerage, you need to fill out some personal details so you are able to buy CLBT today.
Now that you have created your account on investing apps, your next step is to transfer the money for your investment:
Watch this video walkthrough for more details depositing funds into your new brokerage account.
After you have selected the best place to buy Cellebrite DI stock, it's critical to evaluate their stock before you invest, so you can understand the risk as well as the upside.
WallStreetZen was designed to help part-time investors do more accurate fundamental analysis in less time.
You can view all of the due diligence checks on CLBT's stock page.
Investors use a variety of different financial metrics, analyses, models, and charts to gauge CLBT's true value.
Using relative valuations ratios:
You can access more valuation analysis on CLBT's stock here.
Out of 4 Wall Street analysts who research CLBT, the consensus analyst rating on CLBT is a Strong Buy
Please keep in mind that analyst forecasts are not recommendations, nor are they investment advice.
You can dig deeper into what analysts are forecasting on the Cellebrite DI stock forecast page.
Last year, CLBT revenue was $401.20M. Over the past five year, CLBT's revenue has gone up by 18.48% per year. This was faster than the Software - Infrastructure industry average of 17.62%.
Dig into CLBT's earnings and revenue performance here.
Over the last year, executives and large shareholders at CLBT have not bought or sold any shares.
Learn more about who owns CLBT stock here.
No, Cellebrite DI doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other investors have to say.
There are two main options:
Hit the Open button and eToro will execute the order.
If you need additional help buying stocks on eToro, watch the how to video below:
Now that you own some CLBT shares, you'll want to keep up with your new investment.
Create a watchlist to track your CLBT stock.
To summarize, here are the 6 steps to buy Cellebrite DI stock:
If you need a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get the latest news on your new investment in Cellebrite DI, add CLBT to your watchlist by clicking the button below.